• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ARCA biopharma Inc

+ Add to Watchlist

HQ13:GR

0.784 EUR 0.043 5.80%

As of 13:35:55 ET on 12/19/2014.

Snapshot for ARCA biopharma Inc (HQ13)

Open: 0.740 Day's Range: 0.740 - 0.784 Volume: 1,000
Previous Close: 0.741 52wk Range: 0.560 - 1.692 1-Yr Rtn: -29.05%

Stock Chart for HQ13

No chart data available.
  • HQ13:GR 0.750
  • 1D
  • 1M
  • 1Y
0.741
Interactive HQ13 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HQ13

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -
Est. PEG Ratio -
Market Cap (M EUR) 16.58
Shares Outstanding (M) 21.15
30 Day Average Volume 323
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/20/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HQ13

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for HQ13

Arca biopharma, Inc. develops genetically targeted therapies for heart failure and other cardiovascular diseases.

Michael R BristowPresident/CEOPatrick M WheelerChief Financial Officer
Thomas A KeuerChief Operating OfficerChristopher D OzeroffSenior VP/Secretary/Gen Cnsl
More Company Profile & Key Executives for HQ13

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil